Acorda CEO Cohen on U.S. Budget Cuts, Research

March 22 (Bloomberg) -- Ron Cohen, chief executive officer of Acorda Therapeutics Inc., talks about the impact of U.S. budget cuts on medical research and drug development. Cohen, speaking with Sara Eisen and Tom Keene on Bloomberg Television's "Surveillance," also discusses China's investment in medical care and science. (Source: Bloomberg)

Full Show: What'd You Miss? (04/28)
59:53 - Guests include: Billionaire environmental activist Tom Steyer, Cuemacro founder Saeed Amen, Ballard Spahr's Dee Spagnuolo and Meghan Duggan, captain of the U.S. Women's National Hockey team. (Source: Bloomberg)
  • How Virtual Reality Is Impacting Storytelling
  • Quants Fire Back at Paul Tudor Jones
  • Full Show: Bloomberg Best (04/28)